[Retracted] Bone morphogenetic protein and activin membrane‑bound inhibitor suppress bone cancer progression in MG63 and SAOS cells via regulation of the TGF‑β‑induced EMT signaling pathway
Oncology Letters · 09.11.2026 · 33 (1) · 1-1
DOI: 10.3892/ol.2026.15941 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 09.11.2026. Verfasst von Fengsong Liu und 3 weiteren Autor:innen. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Liu, F., Wang, K., Zhang, L., & Yang, Y. L. (2026). [Retracted] Bone morphogenetic protein and activin membrane‑bound inhibitor suppress bone cancer progression in MG63 and SAOS cells via regulation of the TGF‑β‑induced EMT signaling pathway. Oncology Letters, 33(1), 1-1. https://doi.org/10.3892/ol.2026.15941
Vancouver
Liu F, Wang K, Zhang L, Yang YL. [Retracted] Bone morphogenetic protein and activin membrane‑bound inhibitor suppress bone cancer progression in MG63 and SAOS cells via regulation of the TGF‑β‑induced EMT signaling pathway. Oncology Letters. 2026;33(1):1-1. doi:10.3892/ol.2026.15941
BibTeX
@article{Liu2026,
author = {Liu, Fengsong and Wang, Kai and Zhang, Liang and Yang, Ya-Lin},
title = {[Retracted] Bone morphogenetic protein and activin membrane‑bound inhibitor suppress bone cancer progression in MG63 and SAOS cells via regulation of the TGF‑β‑induced EMT signaling pathway},
journal = {Oncology Letters},
year = {2026},
volume = {33},
number = {1},
pages = {1--1},
doi = {10.3892/ol.2026.15941}
}
EUVIMED